Manufacturers of TNF-Blocker Drugs Must Highlight Risk of Fungal Infections

Arthritis Foundation Forum

Home

Welcome Guest ( Login | Register )

Manufacturers of TNF-Blocker Drugs Must...

Rate Topic

Display Mode

Topic Options

Author

Message

AF Dude

Posted Monday, September 08, 2008 12:59 PM

Group: Administrators
Last Login: Yesterday @ 2:35 PM
Posts: 143, Visits: 870

FDA News

In our efforts to provide you with the latest news from Washington DC as it impacts people with arthritis, we are sharing the following press release issued September 4, 2008 from the U.S. Food and Drug Administration, “FDA: Manufacturers of TNF-Blocker Drugs Must Highlight Risk of Fungal Infections”.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01879.html

The Arthritis Foundation recommends that adult patients and parents of children being treated with TNF blockers work closely with their physicians to understand the risks, benefits and side effects clearly. If you have any questions or concerns about your treatment, please consult your physician.

AF Dude
Board Administrator

Post #4157399

Top

« Prev Topic | Next Topic »

All times are GMT -5:00, Time now is 4:52pm

Execution: 0.484. 37 queries. Compression Disabled.